FDA Inspection 1090654 — Gabriel C. Bako, M.D. , Ph.D.
The FDA completed an inspection of Gabriel C. Bako, M.D. , Ph.D. on April 25, 2019 in Oradea. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 25, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Oradea (Romania)
Additional Details
Clinical Investigator (CI)